Advaxis has to know that starting a combo HOT trial with Merck would peeve Amgen off and especially for that indication. Was it on purpose? I think it was, how could it of not been. The question then becomes if that is the case, what do they have cooking with Merck?
News 
Market Data 
Discover 
AI
